JAZMINE MANNS: Open Payments
NPI 1033750328 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 35 payments from 15 companies in 2025. Trend: 2023 $213 · 2024 $865 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $175 |
| Alnylam Pharmaceuticals Inc. | 4 | $165 |
| Edwards Lifesciences Corporation | 1 | $160 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Philips North America LLC | 2 | $34 |
| Amgen Inc. | 2 | $31 |
Products named: LifeVest, JARDIANCE, SAPIEN 3 Ultra RESILIA, AMVUTTRA, LEQVIO, Kerendia, ONPATTRO, VERQUVO.
Industry payments across OK — which companies pay providers there.
